Axon Enterprise, Inc $AXON Shares Acquired by Vontobel Holding Ltd.

Vontobel Holding Ltd. lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 180.5% during the second quarter, Holdings Channel.com reports. The fund owned 12,210 shares of the biotechnology company’s stock after acquiring an additional 7,857 shares during the period. Vontobel Holding Ltd.’s holdings in Axon Enterprise were worth $6,845,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Creative Financial Designs Inc. ADV purchased a new position in shares of Axon Enterprise in the 4th quarter valued at approximately $28,000. Camelot Portfolios LLC purchased a new stake in Axon Enterprise during the 4th quarter worth approximately $30,000. AlphaCentric Advisors LLC purchased a new stake in Axon Enterprise during the 4th quarter worth approximately $34,000. Darwin Wealth Management LLC acquired a new position in Axon Enterprise during the 2nd quarter valued at approximately $37,000. Finally, Strive Financial Group LLC acquired a new position in Axon Enterprise during the 4th quarter valued at approximately $41,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. The Goldman Sachs Group restated a “buy” rating and issued a $715.00 target price on shares of Axon Enterprise in a research note on Thursday, August 6th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a report on Wednesday, August 5th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $730.92.

Insiders Place Their Bets

In other news, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $485.00, for a total value of $753,690.00. Following the sale, the insider owned 34,024 shares in the company, valued at $16,501,640. This represents a 4.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $400.00, for a total value of $800,000.00. Following the sale, the insider directly owned 52,813 shares in the company, valued at approximately $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 68,989 shares of company stock worth $36,016,932. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Trading Down 0.4%

Shares of Axon Enterprise stock opened at $612.83 on Friday. The stock has a market cap of $49.78 billion, a PE ratio of 254.29, a price-to-earnings-growth ratio of 12.56 and a beta of 1.39. The firm has a fifty day moving average price of $526.06 and a 200 day moving average price of $474.40. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $794.29. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.84 by $0.04. The company had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm’s revenue was up 35.3% on a year-over-year basis. During the same period in the prior year, the company earned $2.12 earnings per share. Equities research analysts predict that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.